Phase 1b Study of Isatuximab in combination with bortezomib, cyclophosphamide, and dexamethasone in newly diagnosed, transplant-ineligible multiple myeloma patients

Ocio, E.M. (Enrique M.); Bringhen, S. (Sara); Martínez-López, J. (Joaquín); San-Miguel, J.F. (Jesús F.); Oliva, S. (Stefania); Rodriguez-Otero, P. (Paula); Le-Roux, N. (Nadia); Dong, Y. (Yvonne); Doroumian, S. (Severine); Mace, S. (Sandrine); Mateos, M.V. (María Victoria)

Issue Date:

2023

ISSN:

2572-9241

Note:

This is an open access article distributed under the terms of the Creative Commons AttributionNonCommercial-ShareAlike 4.0 License,

URI:

https://hdl.handle.net/10171/65975

DOI:

10.1097/HS9.0000000000000829

Appears in Collections:

DA - CIMA - Hemato-oncología - Mieloma - Artículos de Revista
DA - CUN - Hematología y Hemoterapia - Artículos de revista

Files in This Item:

File

pdf.pdf

Description

Size

556.56 kB

Format

Adobe PDF

View/Open

Statistics and impact

Statistics

0 citas en

1 citas en

Google Scholar

Show full item record